The study is a cross-sectional study that utilizes an online survey designed to assess the attitudes, knowledge, beliefs, and safety perceptions toward psilocybin-assisted psychotherapy (PAP) for treating bipolar depression among patients within the bipolar spectrum. Participants will also complete a modified version of the Treatment Attitudes Questionnaire (TAQ) to evaluate their attitudes toward their current pharmacological treatments. The study aims to assess the correlation between the attitudes of patients within the bipolar spectrum toward their current treatment and their attitudes, knowledge, beliefs, and safety perceptions regarding PAP. The research involves recruiting participants through diverse online channels, including social media and the Australian National University website, supplemented by MTurk for survey recruitment. Participants meeting inclusion criteria, including age 18 or older, a bipolar disorder diagnosis, informed consent capability, and willingness to engage in the survey, will undergo data collection through a comprehensive web-based questionnaire. The study's data analysis, utilizing quantitative methods, aims to describe sample demographics, analyze attitudes, beliefs, and knowledge about psilocybin, and identify risk perceptions of PAP in bipolar depression treatment. The research respects participant privacy, ensuring a thorough and ethical approach. This project seeks to contribute valuable insights into the correlation between attitudes toward current treatments and perceptions of safety regarding psilocybin-assisted therapy in individuals within the "bipolar spectrum."